gvtcx

Provision of an Auto-Injector Partner

key details

Value£100,000,000
Statusactive
Category (CPV) 24950000 +10 more
RegionSouth West
Deadline30 Jun 2020
Contract start1 Dec 2020
Contract end1 Dec 2035
Procedureselective
SME suitableNo
OCIDocds-b5fd17-c074099d-8639-4d4b-b43b-e30569783de5

description

The UK Ministry of Defence (UK MOD) has an identified and likely future requirement for the production of single and triple therapy auto-injector devices for intramuscular administration. The auto-injectors should be capable of storing up to three Active pharmaceuticals ingredients in a single, dual or triple chambered device. Full operating capability will require the final drug product to be submitted to Regulatory Agencies in the EU and the United Kingdom with the intent for full licensure / marketing authorisation (MA). The Chemical Biological Radiological Nuclear Team (CBRN) is therefore seeking to appoint a partner to manufacture current Auto-injector requirements with future options to manufacture other similar devices as they arise throughout the contractual period.

Additional information: To view this notice, register as a supplier here:

http://www.contracts.mod.uk/delta/signup.html?userType=supplier

and search for the notice with reference 'UK-Bristol: Nuclear, Biological, Chemical and Radiological protection equipment.'.

documents

Documents are linked, not mirrored. They are served by the publishing authority and may require registration.

notice history

2 notices published against this procurement.

PublishedTypeRegimeNotice
1 Jun 2020 Tender (tender) · d1e0cadd-515e-464b-bf5d-385da4fa3df3-361561
27 Jun 2020 Tender (tender) · d0cf832e-b7c6-44b4-a78e-c3e041e19887-366761

more from Ministry of Defence, ISTAR, Chemical, Biological, Radiological and Nuclear Delivery Team (CBRN DT)

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.